Health and Medicine

For drugs anywhere, it's the safety in patients which is a huge issue, constantly under surveillance, irrespective of where the drug is in its pipeline. The Global Pharmaceutical Market currently has a market value of $1057 billion. If a drug is found to be unsafe, causing serious side effects, it can have a huge knock on effect on revenue, causing huge losses to pharmaceutical companies manufacturing the drug. Drug Safety 2018 aims to discuss the latest findings and current thinking on pharmacovigilance. Importantly, it will address the newest regulatory updates and interpretations of them, including the impact of the vital…

IMMH invites you attend our 9th annual conference in Dallas, Texas! Attendees will have the option of attending the full conference (4 days) or the main conference (3 days), as well as the option of choosing between two tracks on day one: IMMH Fundamentals (recommended for first time attendees) or Organic Acids Testing: An Invaluable Tool for All Integrative Practitioners. CME or CE available for specific credentials. This year’s conference has more new speakers and topics than ever before, so be sure to check out the schedule of presentations! We will be hosting a panel and forum discussion on Saturday…

Cancer in the Middle East is on the rise. Poor healthcare access, late presentation and a change in lifestyles have meant that cancer incidence is due to rise faster than any region in the world by 2030, to almost double what it was in 2012. Yet poor data on cancer incidence, mortality and patient satisfaction, makes meeting the challenge all the more difficult. For patients, overcoming the fatalism and stigma surrounding cancer is an additional barrier to treatment. In 2015, The Economist Events declared war on cancer at an inaugural summit in London. Since then, we have taken the conversation…

Psychiatry and mental health narratives have changed extensively over the last centuries. Today, treatment and recovery of mental disorders go hand-in-hand with promotion and prevention and there is an increased interest in rehabilitation and psycho-social interventions. Yet this has not always been the case - these fields of research and intervention have had intricate connections, running in parallel or in confluence, and also sometimes in conflict. Join us in Lisbon, Portugal 21-24 August 2019 to examine crucial issues in psychiatry and mental health, and to hear from leaders on the current scientific and technological revolution in psychiatry. The congress overall…

OVERVIEW The basic provisions of privacy for protected health information are well known in HIPAA. Exceptions abound for various law enforcement purposes as applied to both the federal and state government and its law enforcement activities, including criminal and civil matters. Erase the uncertainty and doubt that exists when the health care practitioner is confronted with a police demand for information. What can you release? To whom? Do you have to notify the patient? Should you notify the patient? What must you document as a permitted disclosure when the police call? Find out in this informative webinar that arms you…

20th Annual congress on Eating Disorders, Obesity and Nutrition July 26-27, 2018 Amsterdam, Netherlands Theme: Emphasizing latest Innovations In The Field of Eating Disorders, Obesity & Nutrition About the conference Conference series welcomes you to 20th Annual congress on Eating Disorders, Obesity and Nutrition going to be held in June26-27, 2018 at Amsterdam, Netherlands. We invite you to join us at, Eating Disorder 2018 where you will be sure to have knowledge with scholars from around the world for a good health. World-renowned speakers, the most recent methods, progresses, and the newest updates in Eating Disorders, Obesity and Nutrition conferences…

The Conference welcomes presentations in any topic that relates to Immunology.

The event will bring together internationally recognised biorepositories, scientific pioneers from pharmaceutical companies, and academics to strengthen current knowledge in biosample management and their research applications. Further, the event will dive into application of novel technologies and security software associated to the protection of data. The conference will aim to broaden the understanding of the ethical and regulatory frameworks, as well as defining the impact that the General Data Protection Regulation (GDPR) will have in 2018. The conference also aims at defining some amongst the most successful applications of biosamples in the market. Speakers are the result of a careful…

Topics covered will include, Genetics/Genomics 101, pharmacogenetics, gene risk scores, genetic purgatory, the molecular autopsy, and the diagnostic, prognostic, and therapeutic implications of genetic testing for patients with congenital heart disease, long QT syndrome, Brugada syndrome, hypertrophic/dilated/arrhythmogenic cardiomyopathy, coronary heart disease, hyperlipidemias, heart failure, pulmonary hypertension, and the aortopathies. Unique Features: Audience response system to enhance immediate feedback. Easy access to faculty members. One-on-one interaction. Efforts will be made to introduce the clinical applications using new technology, however, there is no hands-on experience provided. Self-assessment questions to gage outcome. URLs: Brochure: https://go.evvnt.com/197357-1?pid=154 Inquiries: https://go.evvnt.com/197357-2?pid=154 Prices: MD, PhD, DO, PharmD: USD…

Course "Good Clinical Data Management Practices (GCDMP)" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion. Overview: Why should you attend: Good clinical data management (CDM) is paramount for a successful research. After all, Garbage In, Garbage Out (GIGO). CDM is involved in all aspects of collecting, processing, and interpreting information. There are many types of computer applications and database systems to support data collection and management. However, there are elements of Good Clinical Practice that apply across the board. Review and approval of drugs or devices by regulatory…

Course "eCTD Submissions of IND/NDA to the US FDA, EU and Canada" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion. Overview: The international agreement to assemble all Quality, Safety and Efficacy information for a drug or biologic product into a common format (called the CTD - Common Technical Document) has improved the speed and efficiency for companies working in global development programs and clarified expectations by regulatory bodies. Reformatting for multiple submissions is substantially limited. The CTD has improved the regulatory review processes and enabled implementation of good…

Course "Evolution of the Quality Management System - How to go from Surviving to Thriving" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion. Overview: Using lecture, discussion, and exercises, this 2 day seminar will focus on taking your QMS from surviving to thriving. We'll move from understanding the regulatory requirements, how to create your QMS structure, process thinking, and developing your improvement strategy. We'll discuss tools and techniques for improvement and how to measure your progress. Why you should attend: Many companies struggle to establish and maintain a…

As the demand for information outside of approved labeling continues to rise, the FDA has been called by the industry to provide guidance that governs off-label communications. The regulatory landscape that monitors this space is often blamed for limiting the amount of information received by patients and restricting their ability to make well-informed decisions. Given the public health issues at stake and the public interest involved, it is imperative that this event details the importance of the timely communication of truthful scientific information that currently challenges pharmaceutical, biotech, and medical device professionals. The 2018 Off-Label Regulatory Compliance Congress also explores…

This three-day symposium is designed to provide a comprehensive understanding of the anatomy, clinical aspects, imaging, and management of patients with congenital heart disease. The symposium will include case discussions, didactic seminars, anatomic and imaging correlations, discussion of multimodal imaging and live, hands-on scanning seminars to illustrate the impact of cardiac imaging on treatment, diagnosis, and management of patients with congenital heart disease. URL: Booking: https://go.evvnt.com/197352-1?pid=154 Prices: MD, PhD, DO, PharmD: USD 755 Residents, Sonographers, RN: USD 620 LATE FEE-MD, PhD, DO, PharmD: USD 855 LATE FEE-Residents, Sonographers, RN: USD 720 Time: 7:30 am to 11:45 am

The use of biophysical methods has become pervasive in the drug discovery process, allowing not only to identify low-affinity hits at the screening stage but also to obtain detailed information on target / ligand interactions at more advanced stages (see the review Renaud et al. 2016 Nat. Rev. Drug Discov. 15: 679-698). This is perfectly illustrated by the success of FBDD (fragment-based drug design), where the progress of biophysical techniques in terms of sensitivity, speed, and automation has been instrumental (see the review Erlanson et al. 2016 Nat. Rev. Drug Discov. 15: 605-619). Indeed FBDD is now widely adopted in…

Join Oxford Global for the 2nd Annual Artificial Intelligence in Drug Development Congress, 25-26 September 2018, London where over 250 artificial intelligence and pharmaceutical IT attendees with represent leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions. Across two days, we will bring together 30 presentations and case studies focussed on the innovatice application of artificial intelligence in drug discovery and discovery chemistry, alongside machine learning in clinical trials and cloud computing. Including 3 interactive streams: • AI in Drug Discovery and Discovery Chemistry • Machine Learning and Personalising Patient Treatments • AI in Big Data and Clinical…

Join Oxford Global for the 16th Annual Pharmaceutical IT Congress, 25-26 September 2018, London where over 250 attendees will be representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions. Across two days, we will bring together 27 presentations and case studies focusing on the key development in Big Data, R&D informatics, translation informatics, NGS informatics and bioinformatics, and real-world evidence and real-world data. Including 3 interactive streams: • Big Data Led Strategies & Innovation • R&D Informatics, Translational Informatics, NGS Informatics and Bioinformatics • Management of Real-World Evidence and Real-World Data View Agenda: http://bit.ly/2nLs4cc For further information…

In order to present at the 2nd International Conference on Food Quality, Safety and Security 2018 you have to send your abstract on or before the abstract submission deadline. The abstract must first pass a blind peer review and if accepted by the reviewer, we will send you the abstract acceptance notification. Upon payment of the registration fee, your presentation will be confirmed. Registrations must be done online(https://foodsecurityconference.co/online-registration/), and those who register on or before the Early Bird deadline may enjoy special discounted rate in terms of registration fees(https://foodsecurityconference.co/registration-fees/).

The program consists primarily of clinical cases which illustrate the problems cardiovascular specialists commonly encounter. Multiple choice questions addressing the clinical utility and limitations of echocardiography follow each case. Utilization of cardiac CT and MRI is also incorporated into the cases. In addition, faculty presents “rapid fire” and “unknown” cases. Special breakout sessions are devoted to the interpretation of Doppler hemodynamics, diastolic function, stress echocardiography, congenital heart disease, interventional, heart failure, CT/MRI, and perioperative echocardiography. Attendees have the opportunity to share an interesting case with the faculty and audience. If you would like to share an interesting case, please make…

This is your first and only opportunity to listen to the most advanced clinical case studies from Nektar Therapeutics and Amgen which explore the use of IL-2 to enhance the expansion and activation of the Treg cells. Delve deeper with expert insights from Roche and ILTOO Pharma to understand how IL-2 at low doses could selectively stimulate Treg cells. Identify yourself as a leader in this community and join the discussion exploring the challenges in translating a proof of concept in autoimmune therapies from animal models to clinic. This meeting will provide the platform for conversations to be had to…